CrushSCI.com
142.0Average days
109Median days
19Fastest days
328Longest days
1812025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

74 days

Dauriporphine Suppresses Cell Proliferation, Metastasis, and Stemness of Non‐Small Cell Lung Cancer Through the Regulation of the USP7/CASK

Authors
Pengxiao Hou; Qian WuShow moreShow less
Affiliations
1. Department of Traditional Chinese Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University Taiyuan Shanxi ChinaShow moreShow less
Source PDF DOI Publisher page
19 days

GPCR Precision in Addiction Also Requires Ligand, Exposure, and Phenotype Precision

Authors
Hsin‐Hung Chen; Lien‐Chung WeiShow moreShow less
Affiliations
1. Department of General Psychiatry, Taoyuan Psychiatric Center Ministry of Health and Welfare Taoyuan City Taiwan (Republic of China); 2. Department of Addiction Psychiatry, Taoyuan Psychiatric Center Ministry of Health and Welfare Taoyuan City Taiwan (Republic of China)Show moreShow less
Source PDF DOI Publisher page
221 days

Tricin Inhibits Human Osteosarcoma Cell Metastasis via Suppression of ZNF503 and the PI3K–PIP3–Akt Pathway

Authors
Chia‐Hsuan Chou; Jia‐Sin Yang; Pei‐Ni Chen; Yi‐Hsien Hsieh; Chih‐Hsin Tang; Ya‐Chiu Lin; Shun‐Fa Yang; Ko‐Hsiu LuShow moreShow less
Affiliations
1. Department of Medical Research Chung Shan Medical University Hospital Taichung Taiwan; 2. Institute of Medicine Chung Shan Medical University Taichung Taiwan; 3. Department of Pharmacology, School of Medicine China Medical University Taichung Taiwan; 4. Department of Medical Laboratory Science and Biotechnology Asia University Taichung Taiwan; 5. Chinese Medicine Research Center China Medical University Taichung Taiwan; 6. Department of Orthopedics Chung Shan Medical University Hospital Taichung Taiwan; 7. School of Medicine Chung Shan Medical University Taichung TaiwanShow moreShow less
Source PDF DOI Publisher page
40 days

Targeting CDK‐2 With Novel Indole‐Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies

Authors
Wagdy M. Eldehna; Zainab M. Elsayed; Mohamed R. Elnagar; Yasser M. Omar; Maha‐Hamadien Abdulla; Abdulrahman M. Saleh; Abdelrahman R. Shalabi; Diaaeldin M. Elimam; Suliman Alshamari; Mohamed Fares; Haytham O. TawfikShow moreShow less
Affiliations
1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 2. Scientific Research and Innovation Support Unit, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 3. Department of Pharmacology and Toxicology, Faculty of Pharmacy Al‐Azhar University Cairo Egypt; 4. Department of Pharmacology, College of Pharmacy The Islamic University Najaf Iraq; 5. Institute of Cancer Therapeutics University of Bradford Bradford UK; 6. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy Assiut University Assiut Egypt; 7. Colorectal Research Chair, Department of Surgery, College of Medicine King Saud University Riyadh Saudi Arabia; 8. Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy Cairo University, Cairo University Cairo Egypt; 9. Pharmaceutical Chemistry Department, Faculty of Pharmacy Sinai University North Sinai Egypt; 10. Department of Pharmacognosy, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 11. Sydney Pharmacy School The University of Sydney Sydney New South Wales Australia; 12. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Tanta University Tanta Egypt; 13. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Alsalam University Tanta EgyptShow moreShow less
Source PDF DOI Publisher page
177 days

Alternative Splicing in Cyclin‐Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor‐Positive Breast Cancer

Authors
Yuqiu Cui; Jia Xie; Jiale Cai; Yue Si; Hairong Huang; Shiyi Yu; Haibo SunShow moreShow less
Affiliations
1. School of Medicine (Institute of Translational Medicine) Yangzhou University Yangzhou China; 2. Jiangsu Key Laboratory of Noncoding RNA Fundamental and Clinical Translational Research Yangzhou ChinaShow moreShow less
Source PDF DOI Publisher page
76 days

Applications of Bioinorganic Nano‐Based Delivery Systems—Diagnostics and Therapeutics

Authors
Frank Ssengooba; Jubilee Andrew; Donald FernandesShow moreShow less
Affiliations
1. Department of Pharmacy Practice, School of Pharmacy Sefako Makgatho Health Sciences University Pretoria South Africa; 2. Department of Pharmaceutical Sciences, School of Pharmacy Sefako Makgatho Health Sciences University Pretoria South Africa; 3. Department of Chemistry and Biology Toronto Metropolitan University Toronto Ontario CanadaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.